Résultats de la recherche - 7 results

Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.

a study protocol designed to set up a framework for test validation of SARS-CoV-2 virus assays. Using clinical samples collated from VALCOR, the performance of Aptima SARS-CoV-2 assay was assessed against ...

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.

Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

Bonde, J.; Cocuzza, C.; Zhao, F.H.; S Van Keer; A Vorsters Source: Journal of Clinical Virology, Volume 107 (2018) Keywords: cervical cancer diagnostic test accuracy SCREENING self-sampling Test validation ...

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Vaginal Smears Validation Studies as Topic Abstract: BACKGROUND: Testing for high-risk HPV is more effective in primary cervical cancer screening than the cytological examination of a Pap smear. Separate ...

Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

0.6% inadequate specimens. Based on our study results, we consider the LMNX, similarly to the EIA, useful for HPV-based cervical cancer screening. Health Topics:  Cancer Cancer Kanker Quality of ...

QR code

QR code for this page URL